We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$40.1B
AUM Growth
-$4.93B
(-11%)
Cap. Flow
-$4.88B
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
959
New
32
Increased
238
Reduced
614
Closed
39
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
+$192M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$93.4M |
| 3 |
American Express
AXP
|
+$91.1M |
| 4 |
Prologis
PLD
|
+$86.5M |
| 5 |
AbbVie
ABBV
|
+$84M |
Top Sells
| 1 |
Wells Fargo
WFC
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$197M |
| 3 |
Apple
AAPL
|
+$164M |
| 4 |
RTN
Raytheon Company
RTN
|
+$154M |
| 5 |
Chevron
CVX
|
+$119M |
Sector Composition
| 1 | Technology | 15.87% |
| 2 | Financials | 14.89% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Healthcare | 10.56% |
| 5 | Communication Services | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
DexCom
DXCM
$29.6B
| $1.8M | ﹤0.01% |
48,272
+2,132
| +5% | +$82.8K |
|
727
Mattel
MAT
$4.16B
| $1.8M | ﹤0.01% |
158,112
+4,070
| +3% | +$46.6K |
|
728
Avnet
AVT
$7.03B
| $1.8M | ﹤0.01% |
40,365
-1,366
| -3% | -$59K |
|
|
LPT
729
DELISTED
Liberty Property Trust
LPT
| $1.78M | ﹤0.01% |
34,764
+1,283
| +4% | +$66.1K |
|
|
ONC
730
BeOne Medicines Ltd
ONC
$32.4B
| $1.78M | ﹤0.01% |
14,521
+3,300
| +29% | +$438K |
|
|
LSXMK
731
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $1.78M | ﹤0.01% |
55,612
-268
| -0.5% | -$8.32K |
|
|
JHG
732
DELISTED
Janus Henderson
JHG
| $1.76M | ﹤0.01% |
78,516
-17,365
| -18% | -$361K |
|
733
Autoliv
ALV
$9B
| $1.71M | ﹤0.01% |
21,673
+94
| +0.4% | +$6.7K |
|
734
PBF Energy
PBF
$7.42B
| $1.7M | ﹤0.01% |
62,546
+1,609
| +3% | +$41.1K |
|
|
MPT
735
Medical Properties Trust
MPT
$2.84B
| $1.69M | ﹤0.01% |
86,494
+4,062
| +5% | +$74.6K |
|
736
Melco Resorts & Entertainment
MLCO
$2.12B
| $1.67M | ﹤0.01% |
86,183
-3,179
| -4% | -$69K |
|
737
New Oriental
EDU
$7.82B
| $1.65M | ﹤0.01% |
14,907
-33,785
| -69% | -$3.54M |
|
|
QVCGA
738
DELISTED
QVC Group Inc Series A
QVCGA
| $1.65M | ﹤0.01% |
3,294
-6,568
| -67% | -$3.86M |
|
739
CoreCivic
CXW
$3.03B
| $1.63M | ﹤0.01% |
94,510
+37,722
| +66% | +$663K |
|
740
Twilio
TWLO
$31.4B
| $1.61M | ﹤0.01% |
14,681
+9,291
| +172% | +$1.2M |
|
741
BioMarin Pharmaceuticals
BMRN
$11.5B
| $1.6M | ﹤0.01% |
23,767
+892
| +4% | +$68.7K |
|
742
Jefferies Financial Group
JEF
$12.7B
| $1.59M | ﹤0.01% |
90,357
-85,882
| -49% | -$1.53M |
|
|
CIT
743
DELISTED
CIT Group Inc.
CIT
| $1.59M | ﹤0.01% |
35,077
-87,972
| -71% | -$4.1M |
|
744
Brighthouse Financial
BHF
$3.77B
| $1.58M | ﹤0.01% |
39,038
-1,350
| -3% | -$50.3K |
|
745
Under Armour
UAA
$3.17B
| $1.58M | ﹤0.01% |
79,126
-1,086
| -1% | -$24K |
|
|
VMW
746
DELISTED
VMware, Inc
VMW
| $1.55M | ﹤0.01% |
10,340
+304
| +3% | +$47.9K |
|
747
Liberty Global Class A
LBTYA
$3.52B
| $1.55M | ﹤0.01% |
62,606
-624
| -1% | -$16.6K |
|
|
EXAS
748
DELISTED
Exact Sciences
EXAS
| $1.54M | ﹤0.01% |
17,022
+9,800
| +136% | +$1.12M |
|
749
GoDaddy
GDDY
$12.5B
| $1.53M | ﹤0.01% |
23,176
+831
| +4% | +$56.3K |
|
|
MFA
750
MFA Financial
MFA
$960M
| $1.52M | ﹤0.01% |
+51,750
| New | +$1.51M |
|
Similar funds
Aberdeen Group's Q3 2019 Portfolio in Review
As of Q3 2019, Aberdeen Group held 959 positions worth $40.1B, down 11% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aberdeen Group withdrew a net $4.88B in Q3 2019, closing 39 positions and reducing 614 holdings. Its most notable exit was L3Harris, an estimated $88.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $40.7M.
- Aberdeen Group's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,493,397 shares worth $40.7M.
- Aberdeen Group added most to Fidelity National Information Services in Q3 2019, an estimated $192M increase.
- Aberdeen Group's biggest Q3 2019 reduction was Wells Fargo, cutting an estimated $206M.
- Aberdeen Group fully exited L3Harris in Q3 2019, selling an estimated $88.4M.
- Aberdeen Group's ten largest holdings make up 19% of its $40.1B portfolio in Q3 2019.
- Aberdeen Group opened 32 new positions and closed 39 in Q3 2019.
- Aberdeen Group's portfolio value fell 11% quarter-over-quarter to $40.1B.
Based on Aberdeen Group's 13F filing for Q3 2019, filed 13 Nov 2019.